PharmEasy: A difficult prognosis

Parent API Holdings seems to be banking on FOMO to raise public money at 500% more than what it was valued at nine months ago.

22 November, 202115 min
0
PharmEasy: A difficult prognosis

You may also like

Business
Story image

Duroflex wakes up as Wakefit closes in on an IPO

The six-decade old mattress maker files its draft IPO papers just as Wakefit wins approval for a public market debut—setting up a bruising battle for the No. 2 spot.

Business
Story image

Mankind needs to get its mojo back

Once a stock market darling, the pharma company is bearing the brunt of a costly acquisition.

Internet
Story image

In India’s Lenskart IPO, a success for ADIA

The sovereign wealth fund’s big bet on the Indian eyewear company, Microsoft’s AI win in the Emirates and other updates from the week.